Drug-eluting stent in diabetes

Stein B, Weintraub WS, Gebhart SP, et al. Influence of diabetes mellitus on early and late outcome after percutaneous translu- minal coronary angioplasty. Circulation. 1995;91(4):979-89.

Barzilay JI, Kronmal RA, Bittner V, Eaker E, Evans C, Foster ED. Coronary artery disease and coronary artery bypass graft- ing in diabetic patients aged > or = 65 years (report from the Coronary Artery Surgery Study [CASS] Registry). Am J Cardiol. 1994;74(4):334-9.

Silva JA, Escobar A, Collins TJ, Ramee SR, White CJ. Unstable angina. A comparison of angioscopic findings between diabetic and nondiabetic patients. Circulation. 1995;92(7):1731-6.

Moreno PR, Murcia AM, Palacios IF, et al. Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation. 2000;102(18):2180-84.

Pickup JC, Chusney GD, Thomas SM, Burt D. Plasma in- terleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci. 2000;67(3):291-300.

Marx N, Imhof A, Froehlich J, et al. Effect of rosiglitazone treat- ment on soluble CD40L in patients with type 2 diabetes and coronary artery disease. Circulation. 2003;107(15):1954-7.

Blüher M, Unger R, Rassoul F, Richter V, Paschke R. Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or Type II diabetes. Diabetologia. 2002;45(2):210-6.

Morrison DA, Sethi G, Sacks J, et al. Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME multicenter registry: comparison with the randomized clinical trial. J Am Coll Cardiol. 2002;39(2):266-73.

Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349(14):1315-23.

Schampaert E, Cohen EA, Schlüter M, et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C- SIRIUS). J Am Coll Cardiol. 2004;43(6):1110-5.

Schofer J, Schlüter M, Gershlick AH, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet. 2003;362(9390):1093-9.

Morice MC, Serruys PW, Sousa JE, et al. A randomized compari- son of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346(23):1773-80.

Park SJ, Shim WH, Ho DS, et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med. 2003;348(16):1537-45.

Gershlick A, De Scheerder I, Chevalier B, et al. Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial. Circulation. 2004;109(4):487-93.

Lansky AJ, Costa RA, Mintz GS, et al. Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial. Circulation. 2004;109(16):1948-54.

Grube E, Silber S, Hauptmann KE, et al. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation. 2003;107(1):38-42.

Colombo A, Drzewiecki J, Banning A, et al. Randomized study to assess the effectiveness of slow- and moderate-release poly- mer-based paclitaxel-eluting stents for coronary artery lesions. Circulation. 2003;108(7):788-94.

Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel- eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350(3):221-31.

Grube E. Taxus VI: 9 months results. Insight into diabetics. Euro PCRonline.com. Available from: http://www.europcronline.com/fo/lecture/zoom_diapo.php?id=1234&indice=2. Accessed in 2007 (Oct 23).

Grubeng L. TAXUS VI: Paclitaxel-Eluting Stents for the Treatment of Longer Lesions – Focus on Diabetes. In: European Congress of Cardiology; 2004. Available from: http://www.medscape.com/viewarticle/489421. Accessed in 2007 (Oct 23).

Five-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multivessel coronary disease. A multicenter randomized trial. Writing Group for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators. JAMA. 1997;277(9):715-21.

King SB 3rd, Kosinski AS, Guyton RA, Lembo NJ, Weintraub WS. Eight-year mortality in the Emory Angioplasty versus Sur- gery Trial (EAST). J Am Coll Cardiol. 2000;35(5):1116-21.

Serruys PW, Ong AT, van Herwerden LA, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol. 2005;46(4):575-81.

Zhang Z, Mahoney EM, Stables RH, et al. Disease-specific health status after stent-assisted percutaneous coronary interven- tion and coronary artery bypass surgery: one-year results from the Stent or Surgery trial. Circulation. 2003;108(14):1694-700.

Breeman A, Bertrand ME, Ottervanger JP, et al. Diabetes does not influence treatment decisions regarding revascularization in patients with stable coronary artery disease. Diabetes Care. 2006;29(9):2003-11.

Ben-Gal Y, Moshkovitz Y, Nesher N, et al. Drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus. Ann Thorac Surg. 2006;82(5):1692-7.

Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet. 2007;370(9591):937-48.

Sabaté M, Jiménez-Quevedo P, Angiolillo DJ, et al. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetics patients: the diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation. 2005;112(14):2175-83.

Chan C, Zambahari R, Kaul U, Cohen SA, Buchbinder M. Outcomes in diabetics patients with multivessel disease and long lesions: results from the DECODE STUDY. Am J Cardiol. 2005;96(7A):31H. [abstract].

Baumgart D, Klauss V, Baer F, et al. 1-year results of the SCORPIUS Trial - a German multicenter investigation of the effectiveness of sirolimus-eluting stents in diabetic patients. In: Annual Scientific Meeting of the Transcatheter Cardiovascular Therapeutics. October 22-27. Washington; 2006. [abstract TCT-288]. Available from: http://www.tct2006.com/pdf/Final%20Program%20Relsd.pdf. Accessed in 2007 (Oct 23).